Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies for cancer. The Japanese pharma said its wholly-owned subsidiary Universal ...

The team created a novel cell lineage-tracing model to reveal where the virus hides, and developed genetic profiles of T cells, or white blood cells ... They used humanized mice models to develop a ...

Researchers have developed a new method to grow T cells that have greater longevity and can more efficiently destroy cancer cells in mouse models of melanoma compared to those grown in traditional ...

The team created a novel cell lineage-tracing model to reveal where the virus hides, and developed genetic profiles of T cells ... used humanized mice models to develop a fluorescent red-to ...